Anteris Technologies Global (ASX:AVR) Debt-to-Equity : 0.02 (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Global Debt-to-Equity?

Anteris Technologies Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$1.18 Mil. Anteris Technologies Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$1.02 Mil. Anteris Technologies Global's Total Stockholders Equity for the quarter that ended in Dec. 2024 was A$99.10 Mil. Anteris Technologies Global's debt to equity for the quarter that ended in Dec. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Anteris Technologies Global's Debt-to-Equity or its related term are showing as below:

ASX:AVR' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.14 Max: 1.57
Current: 0.02

During the past 13 years, the highest Debt-to-Equity Ratio of Anteris Technologies Global was 1.57. The lowest was 0.02. And the median was 0.14.

ASX:AVR's Debt-to-Equity is ranked better than
92.71% of 686 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs ASX:AVR: 0.02

Anteris Technologies Global Debt-to-Equity Historical Data

The historical data trend for Anteris Technologies Global's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Global Debt-to-Equity Chart

Anteris Technologies Global Annual Data

Trend

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

1.57

0.40

0.11

0.09

0.02

Anteris Technologies Global Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															0.11	0.14	0.09	0.49	0.02

Competitive Comparison of Anteris Technologies Global's Debt-to-Equity

For the Medical Devices subindustry, Anteris Technologies Global's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anteris Technologies Global's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Anteris Technologies Global Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Anteris Technologies Global's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.184	+	1.018)	/	99.1
	=	0.02

Anteris Technologies Global's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.184	+	1.018)	/	99.1
	=	0.02

Anteris Technologies Global (ASX:AVR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Anteris Technologies Global Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Anteris Technologies Global's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Anteris Technologies Global Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Global Corp (ASX:AVR) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Sherwood Road, Level 3, Suite 302, Toowong, QLD, AUS, 4066

Website

https://www.anteristech.com

Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.